Roche, Novartis Lose French Court Battle Over Off-Label Use Of Avastin In AMD

Rejected
A French court has rejected an attempt to stop Avastin being reimbursed for AMD
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from France

More from Europe